---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-25-000905"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2025-02-12T23:59:59+00:00"
generated_at: "2026-05-26T22:42:43.120345+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel removes preferred stock ownership caps and increases authorized shares to 250M

## Summary
- Stockholders removed Series C and D convertible preferred stock ownership limitations, eliminating conversion caps.
- Authorized common shares increased from 100M to 250M; charter amendment filed Feb 10, 2025.
- David Lazar received 2.1M Series D preferred shares after Series D amendment removal of the 49.99% cap.
- Series C amendment removed 5% ownership limit; Series D removed 49.99% limit.

## SEC filing metadata
- accession: 0001829126-25-000905
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2025-02-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000182912625000905/0001829126-25-000905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000182912625000905/cyclacel_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-25-000905
- JSON: https://secwatch.observer/filing/0001829126-25-000905.json
- Plain text: https://secwatch.observer/filing/0001829126-25-000905.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.